Work

The global burden of Alzheimer’s disease and related dementias: New public health intervention targets driven by the long-term impact of COVID-19 and sex and age differences

Year: 2026
Type: article
Abstract: INTRODUCTION: This study focuses on the impact and future trends of COVID-19 on the burden of Alzheimer's disease and related dementias (ADRD), analyzing multidimensional differences in the burden of disease for ADRD in 204 countries between 1990 and 2021. METHODS: Using Global Burden of Disease (GBD) data (1990-2021), we analyzed Alzheimer's disease and related dementias (ADRD) prevalence and burden across 204 countries, stratified by sex and age. Joinpoint regression identified temporal inflection points in incidence, mortality, disability-adjusted life years (DALYs), and years of life lost (YLL), while age-standardized rates and estimated annual percentage changes assessed global burden trends. We further evaluated ADRD-associated risk factors, quantified COVID-19's impact through excess burden attribution models, and projected incidence trajectories to 2050 via Bayesian Age-Period-Cohort analysis. RESULTS: Global Burden of Disease analyses (1990-2021) show 2021 ADRD incidence of 119.76/100,000, with 450.98 DALYs and 309.03 YLL/100,000. Post-2019 COVID-19 onset, all SDI regions except high-SDI exhibited significant ADRD incidence increases (P < 0.05). Women ≥55 years had the highest burden, with behavioral risks contributing most to DALYs (2021). China showed the steepest ADRD incidence rise (1990-2021), accelerating post-COVID-19, contrasting declines in Denmark and Australia. COVID-19 ASIR (2020) and ADRD ASPR (2020) had a standardized path coefficient of 0.237 (P < 0.05); COVID-19 ASIR (2020) and ADRD ASPR (2021) covariance reached 0.275 (P < 0.05). Projections suggest declining ASIR for ages 40-79 but rising ASIR for ≥80 by 2050. CONCLUSION: To effectively mitigate the ongoing rise in ADRD, particularly among older women and middle-high SDI populations, targeted prevention and control strategies must be developed, with careful consideration of socioeconomic factors and the long-term impacts of COVID-19.
Source: PLoS ONE
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,382
Award: G375068094
OpenAlex ID: W7236186791
FWCI:
Cites: 40
Cited by:
Related to: 10
Parts: 23